Subscribe to the BioNews newsletter for free

Login
Advanced Search

Search for
BioNews

Like the Progress Educational Trust on Facebook


The Fertility Show


 

Stem cell research may help our understanding of schizophrenia

18 April 2011

By Ruth Pidsley

Appeared in BioNews 604

Skin cells from four people with schizophrenia have been successfully reprogrammed into an embryonic-like state and then transformed into brain cells. The research, published in Nature, offers scientists a novel way to study the causes of schizophrenia and the effects of medication on patients.

The team from the Salk Institute for Biological Studies in California found that transformed neurons from people with schizophrenia made fewer nerve connections than similar cells from healthy individuals. The cells' reduced 'neural connectivity' suggests one biological explanation for this neurological disorder.

'This is the first time that a complex mental disease has been modelled in live human cells', said Professor Fred Gage who headed the study. The experiments pave the way for other mental health conditions to be modelled 'in a dish' by similarly reprogramming patients' skin cells to embryonic-like cells and then growing these into different types of neuronal cell.

The work will help in the study of mental health conditions whose underlying biological mechanisms are often difficult to unravel. Environmental factors are known to contribute to these diseases. But Dr Kristen Brennand, who is first author of the study, suggests that 'by growing neurons in a dish we can take the environment out of the equation and start focusing on the underlying biological problems'. 

The technique can also be used to study the effects of medication on patients' own cells. Salk researchers exposed the neurons to five different antipsychotic drugs, and found that the medication loxapine greatly improved the neural connectivity of all patients' neurons, while the other drugs improved the connectivity in at least one patient's cells.

Professor Gage hopes the approach will lead to individualised treatments for patients by helping them establish which drugs are most likely to help them. He said: 'Most psychiatric patients may try many drugs before they find one that works. This may circumvent that process by enabling individualised treatments with the best drug for them'.

In an interview with ABC News, Professor Vaughan Carr, head of the Schizophrenia Research Institute in Australia, said the research is still in its early days as cells have been grown from only four patients, but believes that it has the potential to 'become a very useful technology'.

SOURCES & REFERENCES
ABC Online Australia | 14 April 2011
 
Independent | 14 April 2011
 
Nature | 13 April 2011
 
Nature News | 13 April 2011
 
Irish Times | 14 April 2011
 

RELATED ARTICLES FROM THE BIONEWS ARCHIVE

15 August 2011 - by Mehmet Fidanboylu 
US researchers have linked mutations in 40 genes to sporadic schizophrenia. The evidence suggests that 50 percent of people with schizophrenia without a family history of the condition have 'de novo' DNA mutations that were not passed on from their parents...

28 February 2011 - by Dr Rachael Panizzo 
Scientists have identified a rare gene mutation which they believe is linked to schizophrenia. The researchers from the University of California, San Diego and Trinity College Dublin performed a genome-wide association scan...
20 September 2010 - by Ken Hanscombe 
An international team of researchers has identified a new gene, CYMA5, which is thought to be associated with schizophrenia...
17 May 2010 - by Victoria Kay 
US researchers have identified several genes related to brain function that may increase the risk of developing schizophrenia, according to a new study published in the Proceedings of the National Academy of Sciences....
26 April 2010 - by Dr Tom Dickins and Sima Sandhu 
The models emerging from behavioural biology are increasingly sophisticated. They do not undermine the quest for candidate genes, but rather augment our understanding of why those genes might persist in populations and be differentially expressed across circumstances....
21 December 2009 - by Fenno Outen 
Useful research in mental health care has historically been in short supply. Whether the issue is accurate diagnosis of problems, understanding their causes or the delivery of reliable treatment, there remains plenty of room for progress. For example, it is common for clinicians to disagree about diagnoses or for them to be changed on a regular basis. Furthermore a diagnosis provides a relatively poor guide to effective treatment....

HAVE YOUR SAY
Be the first to have your say.

You need to or  to add comments.

By posting a comment you agree to abide by the BioNews terms and conditions


- click here to enquire about using this story.

Published by the Progress Educational Trust

CROSSING FRONTIERS

Moving the Boundaries of Human Reproduction

Public Conference
London
8 December 2017

Speakers include

Professor Azim Surani

Professor Magdalena Zernicka-Goetz

Professor Robin Lovell-Badge

Sally Cheshire

Professor Guido Pennings

Katherine Littler

Professor Allan Pacey

Dr Sue Avery

Professor Richard Anderson

Dr Elizabeth Garner

Dr Jacques Cohen

Dr Anna Smajdor

Dr Andy Greenfield

Vivienne Parry

Dr Helen O'Neill

Dr César Palacios-González

Philippa Taylor

Fiona Fox

Sarah Norcross


BOOK HERE

Good Fundraising Code

Become a Friend of PET HERE and give the Progress Educational Trust a regular donation